DrugPatentWatch Database Preview
Drugs in Development Information for Fumaric Acid
» See Plans and Pricing
What is the drug development status for Fumaric Acid?
Fumaric Acid is an investigational drug.
There have been 17 clinical trials for Fumaric Acid.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Psoriasis, Sclerosis, and Lupus Erythematosus, Systemic. The leading clinical trial sponsors are Medical University of Vienna, The University of Hong Kong, and Jochen Schmitt.
Summary for Fumaric Acid
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,668 |
| WIPO Patent Applications | 615 |
| Japanese Patent Applications | 3,230 |
| Clinical Trial Progress | Phase 3 (2010-05-01) |
| Vendors | 71 |
Recent Clinical Trials for Fumaric Acid
| Title | Sponsor | Phase |
|---|---|---|
| A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers | Population Health Research Institute | Phase 4 |
| A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis | LEO Pharma | Phase 4 |
| Prospective Randomized Controlled Trial for Prevention of Demineralization During Fixed Orthodontic Treatment | The University of Hong Kong | Phase 2 |
Clinical Trial Summary for Fumaric Acid
Top disease conditions for Fumaric Acid
Top clinical trial sponsors for Fumaric Acid
US Patents for Fumaric Acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
